why choose us

First received: November 16, 2022

Clinical Trial: Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Acute Ischemic Stroke

Study Type: Interventional


Official Title: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-Finding, Multi-center Study to Assess the Efficacy and Safety of Dengzhanxixin Injection in Patients With Acute Ischemic Stroke Receiving

Brief Summary: To assess the Efficacy and Safety of Dengzhanxixin Injection in Patients With Acute Ischemic Stroke Receiving Reperfusion Therapy.

Read more